Common Stock, Shares, Outstanding of CUMBERLAND PHARMACEUTICALS INC from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
CUMBERLAND PHARMACEUTICALS INC quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • CUMBERLAND PHARMACEUTICALS INC Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 14,956,627, a 7.2% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

CUMBERLAND PHARMACEUTICALS INC Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 14,956,627 +1,004,003 +7.2% 31 Dec 2025 10-K 09 Mar 2026 2025 FY
Q3 2025 14,956,627 +945,891 +6.8% 30 Sep 2025 10-Q 07 Nov 2025 2025 Q3
Q2 2025 14,959,937 +876,754 +6.2% 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 14,961,137 +801,183 +5.7% 31 Mar 2025 10-Q 09 May 2025 2025 Q1
Q4 2024 13,952,624 -169,209 -1.2% 31 Dec 2024 10-K 09 Mar 2026 2025 FY
Q3 2024 14,010,736 -207,190 -1.5% 30 Sep 2024 10-Q 08 Nov 2024 2024 Q3
Q2 2024 14,083,183 -247,807 -1.7% 30 Jun 2024 10-Q 09 Aug 2024 2024 Q2
Q1 2024 14,159,954 -270,093 -1.9% 31 Mar 2024 10-Q 10 May 2024 2024 Q1
Q4 2023 14,121,833 -244,483 -1.7% 31 Dec 2023 10-K 07 Mar 2025 2024 FY
Q3 2023 14,217,926 -218,657 -1.5% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 14,330,990 -318,703 -2.2% 30 Jun 2023 10-Q 11 Aug 2023 2023 Q2
Q1 2023 14,430,047 -300,713 -2% 31 Mar 2023 10-Q 12 May 2023 2023 Q1
Q4 2022 14,366,316 -376,438 -2.6% 31 Dec 2022 10-K 13 Mar 2024 2023 FY
Q3 2022 14,436,583 -413,943 -2.8% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 14,649,693 -276,366 -1.9% 30 Jun 2022 10-Q 12 Aug 2022 2022 Q2
Q1 2022 14,730,760 -353,704 -2.3% 31 Mar 2022 10-Q 13 May 2022 2022 Q1
Q4 2021 14,742,754 -245,675 -1.6% 31 Dec 2021 10-K 13 Mar 2023 2022 FY
Q3 2021 14,850,526 -233,846 -1.6% 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 14,926,059 -255,217 -1.7% 30 Jun 2021 10-Q 13 Aug 2021 2021 Q2
Q1 2021 15,084,464 -234,065 -1.5% 31 Mar 2021 10-Q 14 May 2021 2021 Q1
Q4 2020 14,988,429 -275,126 -1.8% 31 Dec 2020 10-K 11 Mar 2022 2021 FY
Q3 2020 15,084,372 -146,906 -0.96% 30 Sep 2020 10-Q 13 Nov 2020 2020 Q2
Q2 2020 15,181,276 -289,794 -1.9% 30 Jun 2020 10-Q 14 Aug 2020 2020 Q2
Q1 2020 15,318,529 -228,988 -1.5% 31 Mar 2020 10-Q 22 May 2020 2019 Q1
Q4 2019 15,263,555 -217,942 -1.4% 31 Dec 2019 10-K 12 Mar 2021 2020 FY
Q3 2019 15,231,278 -324,587 -2.1% 30 Sep 2019 10-Q 13 Nov 2019 2019 Q3
Q2 2019 15,471,070 -133,639 -0.86% 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 15,547,517 -179,733 -1.1% 31 Mar 2019 10-Q 15 May 2019 2019 Q1
Q4 2018 15,481,497 -592,679 -3.7% 31 Dec 2018 8-K 10 Dec 2020
Q3 2018 15,555,865 -225,871 -1.4% 30 Sep 2018 10-Q 14 Nov 2018 2018 Q3
Q2 2018 15,604,709 -332,886 -2.1% 30 Jun 2018 10-Q 14 Aug 2018 2018 Q2
Q1 2018 15,727,250 -338,051 -2.1% 31 Mar 2018 10-Q 09 May 2018 2018 Q1
Q4 2017 16,074,176 0 0% 31 Dec 2017 10-K 12 Mar 2019 2018 FY
Q3 2017 15,781,736 -413,895 -2.6% 30 Sep 2017 10-Q 08 Nov 2017 2017 Q3
Q2 2017 15,937,595 -298,753 -1.8% 30 Jun 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 16,065,301 -231,477 -1.4% 31 Mar 2017 10-Q 15 May 2017 2017 Q1
Q4 2016 16,074,176 -305,325 -1.9% 31 Dec 2016 10-K 09 Mar 2018 2017 FY
Q3 2016 16,195,631 -740,133 -4.4% 30 Sep 2016 10-Q 03 Nov 2016 2016 Q3
Q2 2016 16,236,348 -699,416 -4.1% 30 Jun 2016 10-Q 05 Aug 2016 2016 Q2
Q1 2016 16,296,778 -638,986 -3.8% 31 Mar 2016 10-Q 13 May 2016 2016 Q1
Q4 2015 16,379,501 -739,492 -4.3% 31 Dec 2015 10-K 13 Mar 2017 2016 FY
Q3 2015 16,935,764 -488,061 -2.8% 30 Sep 2015 10-Q 06 Nov 2015 2015 Q3
Q2 2015 16,935,764 -724,603 -4.1% 30 Jun 2015 10-Q 07 Aug 2015 2015 Q2
Q1 2015 16,935,764 -871,553 -4.9% 31 Mar 2015 10-Q 15 May 2015 2015 Q1
Q4 2014 17,118,993 -866,510 -4.8% 31 Dec 2014 10-K 14 Mar 2016 2015 FY
Q3 2014 17,423,825 -734,132 -4% 30 Sep 2014 10-Q 07 Nov 2014 2014 Q3
Q2 2014 17,660,367 -645,997 -3.5% 30 Jun 2014 10-Q 08 Aug 2014 2014 Q2
Q1 2014 17,807,317 -742,432 -4% 31 Mar 2014 10-Q 12 May 2014 2014 Q1
Q4 2013 17,985,503 -951,604 -5% 31 Dec 2013 10-K 09 Mar 2015 2014 FY
Q3 2013 18,157,957 -1,015,889 -5.3% 30 Sep 2013 10-Q 06 Nov 2013 2013 Q3
Q2 2013 18,306,364 -1,392,873 -7.1% 30 Jun 2013 10-Q 09 Aug 2013 2013 Q2
Q1 2013 18,549,749 -1,320,888 -6.6% 31 Mar 2013 10-Q 08 May 2013 2013 Q1
Q4 2012 18,937,107 -1,083,428 -5.4% 31 Dec 2012 10-K 11 Mar 2014 2013 FY
Q3 2012 19,173,846 -1,042,064 -5.2% 30 Sep 2012 10-Q 02 Nov 2012 2012 Q3
Q2 2012 19,699,237 -700,848 -3.4% 30 Jun 2012 10-Q 09 Aug 2012 2012 Q2
Q1 2012 19,870,637 31 Mar 2012 10-Q 04 May 2012 2012 Q1
Q4 2011 20,020,535 -317,926 -1.6% 31 Dec 2011 10-Q 02 Nov 2012 2012 Q3
Q3 2011 20,215,910 30 Sep 2011 10-Q 07 Nov 2011 2011 Q3
Q2 2011 20,400,085 30 Jun 2011 10-Q 08 Aug 2011 2011 Q2
Q4 2010 20,338,461 31 Dec 2010 10-K 07 Mar 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.